1.Mapping the Evolution of IBD Treatment: A Bibliometric Study on Biologics and Small Molecules

Li, HB, Wang, J, Hu,     More...

Li, HB, Wang, J, Hu, Y, Hu, W, Li, J, Liu, Y, Zhao, RS, Zhu, YZ     Less

PHARMACEUTICALS[1424-8247], Published 2025, Volume 18, Issue 3,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2024影響因子:  4.8 

2.From Innovation to Complication: A Case Report and Review on Immune-Related Colitis Induced by ICIs

Li, HB, Pan, YM, Liu     More...

Li, HB, Pan, YM, Liu, WZ, Zhang, HJ, Tian, XL, Zhao, RS, Zhu, YZ     Less

PHARMACEUTICALS[1424-8247], Published 2025, Volume 18, Issue 8,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2024影響因子:  4.8 

3.From a Multi-Omics Signature to a Therapeutic Candidate: Computational Prediction and Experimental Validation in Liver Fibrosis

Qin, YY, Ma, SS, Hon     More...

Qin, YY, Ma, SS, Hong, HY, Zhong, DY, Liang, YX, Su, YH, Chen, YH, Chen, X, Zhu, YZ, Huang, XL     Less

PHARMACEUTICALS[1424-8247], Published 2026, Volume 19, Issue 3,

收錄情况： WOS SCOPUS

2024影響因子:  4.8